Zoetis

ZTS · Health Care · Market cap $31.8B

Q1 FY26 Jan 1 – Mar 31, 2026 reported May 7, 2026

Revenue$2.3B +3% year over year

Gross profit$1.6B

Operating profit$0.7B

Net profit$0.6B 27% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	2.3	100%	+3%
Livestock	0.7	30%
Dermatology	0.3	13%
Other	0.3	13%
Anti Infective Products	0.2	9%	+1%
Pain Sedation	0.2	9%
Other Pharmaceuticals	0.2	9%	+0%
Swine	0.1	4%	+17%
Poultry	0.1	4%
Cost of revenue	−0.6	26%
Gross profit	1.6	72% margin	+0pp
SG&A	−0.6	26%	+0pp
Other	−0.3	13%	+0pp
Operating profit	0.7	33% margin	−2pp
Tax	−0.1
Net profit	0.6	27%	−1pp

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.4	100%	+4%
Parasiticides	0.5	21%
Vaccines	0.5	21%
Dermatology	0.4	17%
Anti Infective Products	0.3	12%	+1%
Other Pharmaceuticals	0.2	8%	+4%
Other	0.2	8%
Swine	0.1	4%	−2%
Poultry	0.1	4%	+0%
Cost of revenue	−0.7	29%
Gross profit	1.7	70% margin	+1pp
SG&A	−0.6	25%	−2pp
Other	−0.3	12%	+0pp
Operating profit	0.8	33% margin	+2pp
Tax	−0.2
Net profit	0.6	26%	+1pp

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.4	100%	+1%
Parasiticides	0.6	25%	+6%
Vaccines	0.5	21%	+6%
Dermatology	0.5	21%
Other	0.2	8%
Pain Sedation	0.2	8%	−7%
Other Pharmaceuticals	0.2	8%	+5%
Swine	0.1	4%	−15%
Animal Health Diagnostics	0.1	4%	+9%
Cost of revenue	−0.7	29%
Gross profit	1.7	72% margin	+1pp
SG&A	−0.6	24%	+0pp
Other	−0.3	11%	+0pp
Operating profit	0.9	36% margin	+0pp
Tax	−0.2
Net profit	0.7	30%	+1pp

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.5	100%	+4%
Livestock	0.6	24%	−8%
Dermatology	0.5	20%	+11%
Cattle	0.3	12%
Other	0.3	12%
Anti Infective Products	0.2	8%	−17%
Pain Sedation	0.2	8%	−2%
Swine	0.1	4%	−8%
Animal Health Diagnostics	0.1	4%	+7%
Cost of revenue	−0.6	24%
Gross profit	1.8	74% margin	+2pp
SG&A	−0.6	25%	+0pp
Other	−0.3	12%	+0pp
Operating profit	0.9	37% margin	+3pp
Tax	−0.2
Net profit	0.7	29%	+3pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q1 FY26	Jan 1 – Mar 31, 2026	May 7, 2026	$2.3B	+3%	30%	$0.6B	27%
Q4 FY25	Oct 1 – Dec 31, 2025	Feb 12, 2026	$2.4B	+4%	33%	$0.6B	26%
Q3 FY25	Jul 1 – Sep 30, 2025	Nov 4, 2025	$2.4B	+1%	38%	$0.7B	30%
Q2 FY25	Apr 1 – Jun 30, 2025	Aug 5, 2025	$2.5B	+4%	36%	$0.7B	29%